vs
REPLIGEN CORP(RGEN)与null(SWIM)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是null的1.7倍($197.9M vs $117.3M),REPLIGEN CORP净利率更高(6.7% vs -7.3%,领先14.0%),REPLIGEN CORP同比增速更快(13.6% vs 5.3%),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs -14.4%)
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
该企业是一家源自美国的跨国律师事务所,1934年创立于加利福尼亚州洛杉矶,在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度,是全球颇具影响力的综合性律所之一。
RGEN vs SWIM — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$117.3M
营收增速更快
RGEN
高出8.4%
5.3%
净利率更高
RGEN
高出14.0%
-7.3%
两年增速更快
RGEN
近两年复合增速
-14.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $197.9M | $117.3M |
| 净利润 | $13.3M | $-8.5M |
| 毛利率 | 52.5% | 31.7% |
| 营业利润率 | 9.0% | — |
| 净利率 | 6.7% | -7.3% |
| 营收同比 | 13.6% | 5.3% |
| 净利润同比 | 143.9% | -43.1% |
| 每股收益(稀释后) | $0.24 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RGEN
SWIM
| Q1 26 | — | $117.3M | ||
| Q4 25 | $197.9M | $100.0M | ||
| Q3 25 | $188.8M | $161.9M | ||
| Q2 25 | $182.4M | $172.6M | ||
| Q1 25 | $169.2M | $111.4M | ||
| Q4 24 | $174.1M | $87.3M | ||
| Q3 24 | $154.9M | $150.5M | ||
| Q2 24 | $154.1M | $160.1M |
净利润
RGEN
SWIM
| Q1 26 | — | $-8.5M | ||
| Q4 25 | $13.3M | $-7.0M | ||
| Q3 25 | $14.9M | $8.1M | ||
| Q2 25 | $14.9M | $16.0M | ||
| Q1 25 | $5.8M | $-6.0M | ||
| Q4 24 | $-30.3M | $-29.2M | ||
| Q3 24 | $-654.0K | $5.9M | ||
| Q2 24 | $3.3M | $13.3M |
毛利率
RGEN
SWIM
| Q1 26 | — | 31.7% | ||
| Q4 25 | 52.5% | 28.0% | ||
| Q3 25 | 53.2% | 35.4% | ||
| Q2 25 | 50.0% | 37.1% | ||
| Q1 25 | 53.6% | 29.5% | ||
| Q4 24 | 26.1% | 24.6% | ||
| Q3 24 | 50.0% | 32.4% | ||
| Q2 24 | 49.8% | 33.1% |
营业利润率
RGEN
SWIM
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | -10.7% | ||
| Q3 25 | 8.9% | 13.3% | ||
| Q2 25 | 7.6% | 14.3% | ||
| Q1 25 | 3.9% | -4.4% | ||
| Q4 24 | -17.7% | -14.9% | ||
| Q3 24 | -5.1% | 8.9% | ||
| Q2 24 | 1.0% | 12.5% |
净利率
RGEN
SWIM
| Q1 26 | — | -7.3% | ||
| Q4 25 | 6.7% | -7.0% | ||
| Q3 25 | 7.9% | 5.0% | ||
| Q2 25 | 8.2% | 9.3% | ||
| Q1 25 | 3.4% | -5.4% | ||
| Q4 24 | -17.4% | -33.4% | ||
| Q3 24 | -0.4% | 3.9% | ||
| Q2 24 | 2.2% | 8.3% |
每股收益(稀释后)
RGEN
SWIM
| Q1 26 | — | $-0.07 | ||
| Q4 25 | $0.24 | $-0.06 | ||
| Q3 25 | $0.26 | $0.07 | ||
| Q2 25 | $0.26 | $0.13 | ||
| Q1 25 | $0.10 | $-0.05 | ||
| Q4 24 | $-0.55 | $-0.24 | ||
| Q3 24 | $-0.01 | $0.05 | ||
| Q2 24 | $0.06 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $767.6M | — |
| 总债务越低越好 | $542.2M | $3.3M |
| 股东权益账面价值 | $2.1B | $396.7M |
| 总资产 | $2.9B | $856.4M |
| 负债/权益比越低杠杆越低 | 0.26× | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
RGEN
SWIM
| Q1 26 | — | — | ||
| Q4 25 | $767.6M | — | ||
| Q3 25 | $748.7M | — | ||
| Q2 25 | $708.9M | — | ||
| Q1 25 | $697.2M | — | ||
| Q4 24 | $757.4M | — | ||
| Q3 24 | $784.0M | — | ||
| Q2 24 | $809.1M | — |
总债务
RGEN
SWIM
| Q1 26 | — | $3.3M | ||
| Q4 25 | $542.2M | $279.8M | ||
| Q3 25 | $537.9M | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | $525.6M | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M |
股东权益
RGEN
SWIM
| Q1 26 | — | $396.7M | ||
| Q4 25 | $2.1B | $405.9M | ||
| Q3 25 | $2.1B | $408.4M | ||
| Q2 25 | $2.1B | $398.4M | ||
| Q1 25 | $2.0B | $381.1M | ||
| Q4 24 | $2.0B | $387.2M | ||
| Q3 24 | $2.0B | $416.6M | ||
| Q2 24 | $2.0B | $408.1M |
总资产
RGEN
SWIM
| Q1 26 | — | $856.4M | ||
| Q4 25 | $2.9B | $823.2M | ||
| Q3 25 | $2.9B | $844.4M | ||
| Q2 25 | $2.9B | $822.1M | ||
| Q1 25 | $2.9B | $824.6M | ||
| Q4 24 | $2.8B | $794.2M | ||
| Q3 24 | $2.8B | $853.4M | ||
| Q2 24 | $2.9B | $830.0M |
负债/权益比
RGEN
SWIM
| Q1 26 | — | 0.01× | ||
| Q4 25 | 0.26× | 0.69× | ||
| Q3 25 | 0.26× | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | 0.27× | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $25.7M | $-47.7M |
| 自由现金流经营现金流 - 资本支出 | $17.6M | — |
| 自由现金流率自由现金流/营收 | 8.9% | — |
| 资本支出强度资本支出/营收 | 4.1% | — |
| 现金转化率经营现金流/净利润 | 1.93× | — |
| 过去12个月自由现金流最近4个季度 | $93.9M | — |
8季度趋势,按日历期对齐
经营现金流
RGEN
SWIM
| Q1 26 | — | $-47.7M | ||
| Q4 25 | $25.7M | $23.3M | ||
| Q3 25 | $48.1M | $51.0M | ||
| Q2 25 | $28.6M | $36.0M | ||
| Q1 25 | $15.0M | $-46.9M | ||
| Q4 24 | $39.2M | $6.2M | ||
| Q3 24 | $49.3M | $37.2M | ||
| Q2 24 | $42.2M | $52.4M |
自由现金流
RGEN
SWIM
| Q1 26 | — | — | ||
| Q4 25 | $17.6M | $14.1M | ||
| Q3 25 | $43.4M | $45.2M | ||
| Q2 25 | $21.5M | $29.1M | ||
| Q1 25 | $11.4M | $-50.3M | ||
| Q4 24 | $33.6M | $-98.0K | ||
| Q3 24 | $42.3M | $33.2M | ||
| Q2 24 | $37.4M | $47.9M |
自由现金流率
RGEN
SWIM
| Q1 26 | — | — | ||
| Q4 25 | 8.9% | 14.1% | ||
| Q3 25 | 23.0% | 27.9% | ||
| Q2 25 | 11.8% | 16.8% | ||
| Q1 25 | 6.8% | -45.2% | ||
| Q4 24 | 19.3% | -0.1% | ||
| Q3 24 | 27.3% | 22.1% | ||
| Q2 24 | 24.3% | 29.9% |
资本支出强度
RGEN
SWIM
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 9.2% | ||
| Q3 25 | 2.5% | 3.6% | ||
| Q2 25 | 3.9% | 4.0% | ||
| Q1 25 | 2.1% | 3.1% | ||
| Q4 24 | 3.2% | 7.2% | ||
| Q3 24 | 4.5% | 2.7% | ||
| Q2 24 | 3.1% | 2.8% |
现金转化率
RGEN
SWIM
| Q1 26 | — | — | ||
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.23× | 6.29× | ||
| Q2 25 | 1.92× | 2.25× | ||
| Q1 25 | 2.57× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | 12.70× | 3.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图